ASF1A and chronic myelogenous leukemia, BCR-ABL1 positive: DMSO, ATRA, and PMA are different inducers for CML cell differentiation [23], and treatment with these inducers greatly suppressed the mRNA and protein expression of ASF1A in K562 and MEG01 cells (Fig. 1d–g).